Background: We proposed a new method to estimate dry weight (DW) using single frequency bioimpedance. Methods: We hypothesized that the change in whole body resistance at 50 kHz (R50) was proportional to the ultrafiltration volume (UFV) during a hemodialysis (HD) session. When the targeted resistance estimated in healthy subjects was reached, the patient achieved his/her DW. UFV and R50 were monitored in 40 HD patients. Another 43 HD patients were stratified into 2 groups to validate this method. Results: The change in whole body resistance was proportional to UFV in each of the 40 HD patients. In the DWdecrease group, pre-dialysis systolic blood pressure (n = 29, 154.5 ± 22.8 vs. 146.9 ± 22.3, p < 0.05) and antihypertensive medicine (4.7 ± 3.6 vs. 3.3 ± 2.2, p < 0.05) decreased without adverse symptoms change. In the DWincrease group, the number of adverse symptoms in 1 week (n = 14, 26 vs. 6, p < 0.05) decreased without a change in systolic blood pressure. Conclusion: This method may become a convenient and cheaper way to estimate DW in HD patients.

Daugirdas JT, Blake PG, Ing TS: Handbook of Dialysis. Baltimore, Lippincott Williams, 2007.
Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009;24:1574–1579.
Bos WJ, van Manen JG, Noordzij M, Boeschoten EW, Krediet RT, Dekker FW: Is the inverse relation between blood pressure and mortality normalized in ‘low-risk’ dialysis patients? J Hypertens 2010;28:439–445.
Ozkahya M, Ok E, Toz H, Asci G, Duman S, Basci A, Kose T, Dorhout ME: Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 2006;21:3506–3513.
Kraemer M, Rode C, Wizemann V: Detection limit of methods to assess fluid status changes in dialysis patients. Kidney Int 2006;69:1609–1620.
Piccoli A: Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis. The Italian Hemodialysis-Bioelectrical Impedance Analysis (HD-BIA) Study Group. Kidney Int 1998;53:1036–1043.
Chamney PW, Kramer M, Rode C, Kleinekofort W, Wizemann V: A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int 2002;61:2250–2258.
Chamney PW, Wabel P, Moissl UM, Muller MJ, Bosy-Westphal A, Korth O, Fuller NJ: A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 2007;85:80–89.
Matthie JR: Second generation mixture theory equation for estimating intracellular water using bioimpedance spectroscopy. J Appl Physiol 2005;99:780–781.
Moissl UM, Wabel P, Chamney PW, Bosaeus I, Levin NW, Bosy-Westphal A, Korth O, Muller MJ, Ellegard L, Malmros V, Kaitwatcharachai C, Kuhlmann MK, Zhu F, Fuller NJ: Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas 2006;27:921–933.
Zhu F, Kuhlmann MK, Kotanko P, Seibert E, Leonard EF, Levin NW: A method for the estimation of hydration state during hemodialysis using a calf bioimpedance technique. Physiol Meas 2008;29:S503–S516.
Charra B, Laurent G, Chazot C, Calemard E, Terrat JC, Vanel T, Jean G, Ruffet M: Clinical assessment of dry weight. Nephrol Dial Transplant 1996;11(suppl 2):16–19.
World Health Organization Collaborating Centre for Drug Statistics Methodology: Anatomical therapeutic chemical (ATC) classification system: guidelines for ATC classification and DDD assignment. Available at:, 2009.
Zhu F, Leonard EF, Levin NW: Extracellular fluid redistribution during hemodialysis: bioimpedance measurement and model. Physiol Meas 2008;29:S491–S501.
Zhu F, Schneditz D, Wang E, Martin K, Morris AT, Levin NW: Validation of changes in extracellular volume measured during hemodialysis using a segmental bioimpedance technique. ASAIO J 1998;44:M541–M545.
Zhu F, Schneditz D, Wang E, Levin NW: Dynamics of segmental extracellular volumes during changes in body position by bioimpedance analysis. J Appl Physiol 1998;85:497–504.
Weir MR: Relative plasma volume monitoring and blood pressure control: an overlooked opportunity to achieve dry weight in the hemodialysis patient. Hypertension 2010;55:226–227.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.